Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Chemo ± immunotherapy remains utilized for chronic lymphocytic lymphoma in the real-world practice: Unmet needs, treatment patterns, and age disparities in the United States

Javier Pinilla-Ibarz, Swetha Challagulla, Qianhong Fu, Pengfei Cheng, Mei Xue, Keri Yang

Blood (2025) 146 (Supplement 1): 2762.

https://doi.org/10.1182/blood-2025-2762

Published: 2025

Journal Articles

Evaluating patient preferences for chronic lymphocytic leukemia (CLL) in Korea: A discrete choice experiment

Byung Woo Yoon, Suhyeon Lee, Mei Xue, Yan Meng, Dominic Pilon, Fengyi Jiang, Keri Yang, Sikander Ailawadhi

Blood (2025) 146 (Supplement 1): 7923.

https://doi.org/10.1182/blood-2025-7923

Published: 2025

Journal Articles

Patient preferences and factors affecting patient treatment decisions for chronic lymphocytic leukemia (CLL) in Japan

Hirohiko Shibayama, Junji Suzumiya, Kuniharu Matsuno, Kazuki Kiyose, Mei Xue, Yan Meng, Todor I. Totev, Zhuo Chen, Keri Yang, Sikander Ailawadhi

Blood (2025) 146 (Supplement 1): 4406.

https://doi.org/10.1182/blood-2025-4406

Published: 2025

Journal Articles

Real-world treatment utilization, sequencing, and outcomes in Mantle Cell Lymphoma: Emerging treatment patterns in the United States

Alvaro Alencar, Mei Xue, Qianhong Fu, Dong Yuan, Swetha Challagulla, Keri Yang

Blood (2025) 146 (Supplement 1): 8020.

https://doi.org/10.1182/blood-2025-8020

Published: 2025

Journal Articles

Patients with high-risk features in Mantle Cell Lymphoma: A systematic literature review of clinical trials and real-world studies

Christine Ryan, Swetha Challagulla, Wesley Furnback, Mei Xue, Keri Yang, Alvaro Alencar

Blood (2025) 146 (Supplement 1): 8103.

https://doi.org/10.1182/blood-2025-8103

Published: 2025

Journal Articles

Number needed to treat to avoid progression or death: Zanubrutinib vs other COVALENT bruton tyrosine kinase inhibitors in Relapsed/Refractory chronic lymphocytic leukemia

Mazyar Shadman, Jennifer Brown, David Campbell, Mei Xue, Marjan Massoudi, Rhys Williams, Keri Yang, Constantine Tam

Blood (2025) 146 (Supplement 1): 4553.

https://doi.org/10.1182/blood-2025-4553

Published: 2025

Journal Articles

Patient Medication Preferences in Follicular Lymphoma (FL) in the United States (USA): A Discrete-Choice Experiment (DCE)

Sameh Gaballa, Mei Xue, Todor I Totev, Yan Meng, Swetha Challagulla, Zhuo Chen, Keri Yang

Blood (2024) 144 (Supplement 1): 3655.

https://doi.org/10.1182/blood-2024-204187

Published: 2024

Journal Articles

Prospective Patient Preference Study for Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment Attributes and Factors Affecting Patient Shared Decision-Making in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) in the United States (USA)

Sikander Ailawadhi, Swetha Challagulla, Dominic Pilon, Yan Meng, Mei Xue, Yuxi Wang, Keri Yang

Blood (2024) 144 (Supplement 1): 2265.

https://doi.org/10.1182/blood-2024-202786

Published: 2024

Journal Articles

Triple-Drug Regimen for Naïve MDS and AML Patients: Efficacy and Safety of Chidamide, Azacitidine, and Venetoclax in a Prospective Multicenter Study

Min Zhang, Miaomiao Zhao, Renying Ge, Xie-Na Cao, Mei Xue, Jing He, Zhaodong Zhong, Xin Fu

Blood (2024) 144 (Supplement 1): 6080.

https://doi.org/10.1182/blood-2024-204432

Published: 2024

Journal Articles

Real-World Patterns of Care and Financial Burden of Patients with Follicular Lymphoma in the United States

Bijal D. Shah, Mei Xue, Erlene Kuizon Seymour, Wesley Furnback, Po-Ya Chuang, Keri Yang

Blood (2023) 142 (Supplement 1): 5137.

https://doi.org/10.1182/blood-2023-179556

Published: 2023

Journal Articles

Similar Efficacy of Ibrutinib Arms across ALPINE and ELEVATE-RR Trials in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison

Mazyar Shadman, Alessandra Tedeschi, Leyla Mohseninejad, Keri Yang, Nicole Lamanna, Sheng Xu, Aileen Cleary Cohen, Swetha Challagulla, Mei Xue, Rhys Williams, Susan M. O'Brien, Jennifer R. Brown, Constantine S. Tam

Blood (2023) 142 (Supplement 1): 4655.

https://doi.org/10.1182/blood-2023-179222

Published: 2023

Journal Articles

Clinical and Genetic Characteristics of 30 Patients Misdiagnosed As Having ITP with Non-Muscle Myosin Heavy Chain 9-Related Disease (MYH9-RD): A Retrospective Analysis in China

Yadan Wang, Abdul Rehman Arif, Yajie Ding, Wenlan Chen, Li Cai, Mei Xue, Jun Deng, Heng Mei

Blood (2023) 142 (Supplement 1): 2597.

https://doi.org/10.1182/blood-2023-174313

Published: 2023

Journal Articles

Real-World Switching Pattern, Persistence, and Associated Healthcare Resource Utilization of Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma in the United States

Bijal D. Shah, Mei Xue, Wesley Furnback, Kaitlyn Esselman, Po-Ya Chuang, Keri Yang

Blood (2023) 142 (Supplement 1): 5155.

https://doi.org/10.1182/blood-2023-178787

Published: 2023

Journal Articles

Number Needed to Treat Analyses of Zanubrutinib in Relapsed/Refractory Chronic Lymphocytic Leukaemia

Asher Alban Chanan-Khan, Kirollos S. Hanna, Mei Xue, Marjan Massoudi, Mark Balk, Hossein ZivariPiran, Cecilia Duan, Keri Yang

Blood (2023) 142 (Supplement 1): 2337.

https://doi.org/10.1182/blood-2023-174709

Published: 2023

Journal Articles

Daratumumab Dose Analysis Among Patients with Multiple Myeloma in a US Community Oncology Setting: A Retrospective Observational Study in Integra Connect Network

Robert E Smith, MD, Mei Xue, Stanley M. Marks, MD, Jeffrey A. Scott, MD, Simon Blanc, Neil Nagovski, MD, Hunter Lambert, Prateesh Varughese

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-139844

Published: 2020

Journal Articles

Healthcare Resource Utilization with Rasburicase in the Management of Patients with Tumor Lysis in the Outpatient Setting: Results from a Community Oncology Cohort

Ali McBride, PharmD,MS, Melissa Hagan, PhD, Mei Xue, MBA, Robert E Smith, MD

Blood (2019) 134 (Supplement_1): 3401.

https://doi.org/10.1182/blood-2019-125922

Published: 2019

Journal Articles

Haploidentical Hematopoietic Stem Cell Transplantation In Hematologic Malignancies with G-CSF Mobilized Bone Marrow Plus Peripheral Blood Stem Cells Grafts without T Cell Depletion: a Single Center Report of 29 Cases

Hengxiang Wang, Hongmin Yan, Zhidong Wang, Mei Xue, Ling Zhu, Jing Liu, Li Ding

Blood (2010) 116 (21): 3552.

https://doi.org/10.1182/blood.V116.21.3552.3552

Published: 2010

Journal Articles

Haploidentical Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma with Bone Marrow Involvement.

HengXiang Wang, Mei Xue, Jing Liu, Hong-Min Yan, Lian-Ning Duan, Ling Zhu, Zhi-Dong Wang

Blood (2009) 114 (22): 5124.

https://doi.org/10.1182/blood.V114.22.5124.5124

Published: 2009

Journal Articles

Haploidentical Hematopoietic Stem Cell Transplantation in Children Leukemia and Lymphoma with G-CSF Mobilized Marrow Grafts without T Cell Depletion: A Single Center Report of 45 Cases.

HengXiang Wang, Hong-Min Yan, Lian-Ning Duan, Ling Zhu, Mei Xue, Jing Liu

Blood (2008) 112 (11): 3282.

https://doi.org/10.1182/blood.V112.11.3282.3282

Published: 2008

Journal Articles

A Experimental Study and Clinical Result of Prophylaxis aGVHD with Humanized Anti-CD25 Monoclonal Antibody in Haploidentical BMT.

Shu-Quan Ji, MD, Hui-Ren Chen, MD, Heng-Xiang Wang, Hong-Min Yan, Mei Xue, Jing Liu, Chang-Q.(Micky) Xun, MD

Blood (2004) 104 (11): 1251.

https://doi.org/10.1182/blood.V104.11.1251.1251

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Chemo ± immunotherapy remains utilized for chronic lymphocytic lymphoma in the real-world practice: Unmet needs, treatment patterns, and age disparities in the United States

Evaluating patient preferences for chronic lymphocytic leukemia (CLL) in Korea: A discrete choice experiment

Patient preferences and factors affecting patient treatment decisions for chronic lymphocytic leukemia (CLL) in Japan

Real-world treatment utilization, sequencing, and outcomes in Mantle Cell Lymphoma: Emerging treatment patterns in the United States

Patients with high-risk features in Mantle Cell Lymphoma: A systematic literature review of clinical trials and real-world studies

Number needed to treat to avoid progression or death: Zanubrutinib vs other COVALENT bruton tyrosine kinase inhibitors in Relapsed/Refractory chronic lymphocytic leukemia

Patient Medication Preferences in Follicular Lymphoma (FL) in the United States (USA): A Discrete-Choice Experiment (DCE)

Prospective Patient Preference Study for Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment Attributes and Factors Affecting Patient Shared Decision-Making in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) in the United States (USA)

Triple-Drug Regimen for Naïve MDS and AML Patients: Efficacy and Safety of Chidamide, Azacitidine, and Venetoclax in a Prospective Multicenter Study

Real-World Patterns of Care and Financial Burden of Patients with Follicular Lymphoma in the United States

Similar Efficacy of Ibrutinib Arms across ALPINE and ELEVATE-RR Trials in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison

Clinical and Genetic Characteristics of 30 Patients Misdiagnosed As Having ITP with Non-Muscle Myosin Heavy Chain 9-Related Disease (MYH9-RD): A Retrospective Analysis in China

Real-World Switching Pattern, Persistence, and Associated Healthcare Resource Utilization of Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma in the United States

Number Needed to Treat Analyses of Zanubrutinib in Relapsed/Refractory Chronic Lymphocytic Leukaemia

Daratumumab Dose Analysis Among Patients with Multiple Myeloma in a US Community Oncology Setting: A Retrospective Observational Study in Integra Connect Network

Healthcare Resource Utilization with Rasburicase in the Management of Patients with Tumor Lysis in the Outpatient Setting: Results from a Community Oncology Cohort

Haploidentical Hematopoietic Stem Cell Transplantation In Hematologic Malignancies with G-CSF Mobilized Bone Marrow Plus Peripheral Blood Stem Cells Grafts without T Cell Depletion: a Single Center Report of 29 Cases

Haploidentical Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma with Bone Marrow Involvement.

Haploidentical Hematopoietic Stem Cell Transplantation in Children Leukemia and Lymphoma with G-CSF Mobilized Marrow Grafts without T Cell Depletion: A Single Center Report of 45 Cases.

A Experimental Study and Clinical Result of Prophylaxis aGVHD with Humanized Anti-CD25 Monoclonal Antibody in Haploidentical BMT.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only